RaySearch Laboratories AB (publ) (RAY-B) - Total Assets

Latest as of September 2025: Skr1.94 Billion SEK ≈ $209.24 Million USD

Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) holds total assets worth Skr1.94 Billion SEK (≈ $209.24 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See RAY-B net asset value for net asset value and shareholders' equity analysis.

RaySearch Laboratories AB (publ) - Total Assets Trend (2003–2024)

This chart illustrates how RaySearch Laboratories AB (publ)'s total assets have evolved over time, based on quarterly financial data.

RaySearch Laboratories AB (publ) - Asset Composition Analysis

Current Asset Composition (December 2024)

RaySearch Laboratories AB (publ)'s total assets of Skr1.94 Billion consist of 47.1% current assets and 52.9% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr462.74 Million 22.1%
Accounts Receivable Skr468.13 Million 22.4%
Inventory Skr10.62 Million 0.5%
Property, Plant & Equipment Skr526.66 Million 25.2%
Intangible Assets Skr548.17 Million 26.2%
Goodwill Skr0.00 0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how RaySearch Laboratories AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see RaySearch Laboratories AB (publ) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: RaySearch Laboratories AB (publ)'s current assets represent 47.1% of total assets in 2024, a decrease from 74.1% in 2003.
  • Cash Position: Cash and equivalents constituted 22.1% of total assets in 2024, up from 20.2% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 18.0% in 2003.
  • Asset Diversification: The largest asset category is intangible assets at 26.2% of total assets.

RaySearch Laboratories AB (publ) Competitors by Total Assets

Key competitors of RaySearch Laboratories AB (publ) based on total assets are shown below.

Company Country Total Assets
Longmaster Information Tech
SHE:300288
China CN¥1.33 Billion
Echoiq Ltd
AU:EIQ
Australia AU$17.99 Million
ARTRYA Ltd
AU:AYA
Australia AU$23.68 Million
Pharmx Technologies Ltd
AU:PHX
Australia AU$18.82 Million
Intelicare Holdings Ltd
AU:ICR
Australia AU$1.64 Million
Global Health Ltd
AU:GLH
Australia AU$2.84 Million
Newtopia Inc
V:NEWU
Canada CA$664.83K
Pro Medicus Ltd
AU:PME
Australia AU$533.91 Million

RaySearch Laboratories AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.59 1.30 1.35
Quick Ratio 1.55 1.27 1.33
Cash Ratio 0.56 0.61 0.00
Working Capital Skr338.10 Million Skr206.82 Million Skr149.15 Million

RaySearch Laboratories AB (publ) - Advanced Valuation Insights

This section examines the relationship between RaySearch Laboratories AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 6.54
Latest Market Cap to Assets Ratio 0.30
Asset Growth Rate (YoY) 7.1%
Total Assets Skr2.09 Billion
Market Capitalization $625.45 Million USD

Valuation Analysis

Below Book Valuation: The market values RaySearch Laboratories AB (publ)'s assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: RaySearch Laboratories AB (publ)'s assets grew by 7.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for RaySearch Laboratories AB (publ) (2003–2024)

The table below shows the annual total assets of RaySearch Laboratories AB (publ) from 2003 to 2024.

Year Total Assets Change
2024-12-31 Skr2.09 Billion
≈ $225.04 Million
+7.09%
2023-12-31 Skr1.95 Billion
≈ $210.14 Million
+4.09%
2022-12-31 Skr1.88 Billion
≈ $201.88 Million
+7.87%
2021-12-31 Skr1.74 Billion
≈ $187.15 Million
+35.34%
2020-12-31 Skr1.28 Billion
≈ $138.28 Million
+1.64%
2019-12-31 Skr1.26 Billion
≈ $136.05 Million
+14.37%
2018-12-31 Skr1.11 Billion
≈ $118.96 Million
+20.80%
2017-12-31 Skr915.06 Million
≈ $98.48 Million
+27.58%
2016-12-31 Skr717.25 Million
≈ $77.19 Million
+48.04%
2015-12-31 Skr484.49 Million
≈ $52.14 Million
+24.31%
2014-12-31 Skr389.75 Million
≈ $41.94 Million
+30.28%
2013-12-31 Skr299.16 Million
≈ $32.19 Million
+2.09%
2012-12-31 Skr293.03 Million
≈ $31.53 Million
+12.27%
2011-12-31 Skr261.00 Million
≈ $28.09 Million
+1.98%
2010-12-31 Skr255.93 Million
≈ $27.54 Million
+9.79%
2009-12-31 Skr233.10 Million
≈ $25.09 Million
+23.93%
2008-12-31 Skr188.09 Million
≈ $20.24 Million
+8.58%
2007-12-31 Skr173.23 Million
≈ $18.64 Million
+18.43%
2006-12-31 Skr146.27 Million
≈ $15.74 Million
+36.47%
2005-12-31 Skr107.18 Million
≈ $11.53 Million
+135.99%
2004-12-31 Skr45.42 Million
≈ $4.89 Million
+47.67%
2003-12-31 Skr30.76 Million
≈ $3.31 Million
--

About RaySearch Laboratories AB (publ)

ST:RAY-B Sweden Health Information Services
Market Cap
$625.45 Million
Skr5.81 Billion SEK
Market Cap Rank
#11392 Global
#178 in Sweden
Share Price
Skr188.70
Change (1 day)
+3.80%
52-Week Range
Skr168.40 - Skr365.50
All Time High
Skr365.50
About

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a tre… Read more